Loading...
Comparison of CRISPR/Cas Endonucleases for in vivo Retinal Gene Editing
CRISPR/Cas has opened the prospect of direct gene correction therapy for some inherited retinal diseases. Previous work has demonstrated the utility of adeno-associated virus (AAV) mediated delivery to retinal cells in vivo; however, with the expanding repertoire of CRISPR/Cas endonucleases, it is n...
Na minha lista:
| Udgivet i: | Front Cell Neurosci |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7511709/ https://ncbi.nlm.nih.gov/pubmed/33132845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fncel.2020.570917 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|